SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001349929-17-000094
Filing Date
2017-11-28
Accepted
2017-11-28 16:56:21
Documents
3
Period of Report
2017-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_151190616718359.html 3  
1 FORM 3 wf-form3_151190616718359.xml 3 1676
2 WIDMANN POA widmannpoa.htm EX-24 604
3 WIDMANN POA widmannpoa001.jpg GRAPHIC 176812
  Complete submission text file 0001349929-17-000094.txt   247423
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Issuer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 201 ROUTE 17 N. 2ND FLOOR RUTHERFORD NJ 07070
Business Address
Widmann Thomas F (Reporting) CIK: 0001723801 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35817 | Film No.: 171226000